Nanjing Hicin Pharmaceutical Co., Ltd. (300584) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nanjing Hicin Pharmaceutical Co., Ltd.

Why is Nanjing Hicin Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 4.33%

The company has been able to generate a Return on Capital Employed (avg) of 4.33% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -4.82% and Operating profit at -9.53% over the last 5 years

Flat results in Sep 25

PRE-TAX PROFIT(Q) At CNY 3.52 MM has Fallen at -69.53%
NET PROFIT(Q) At CNY 3.52 MM has Fallen at -68.45%
INTEREST COVERAGE RATIO(Q) Lowest at 220.11

With ROE of 4.26%, it has a very expensive valuation with a 6.38 Price to Book Value

Over the past year, while the stock has generated a return of 95.24%, its profits have risen by 6.6% ; the PEG ratio of the company is 22.7
At the current price, the company has a high dividend yield of 0.1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Hicin Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nanjing Hicin Pharmaceutical Co., Ltd.

108.0%

1.71

85.62%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.82%

EBIT Growth (5y)

-9.53%

EBIT to Interest (avg)

5.66

Debt to EBITDA (avg)

1.66

Net Debt to Equity (avg)

0.25

Sales to Capital Employed (avg)

0.40

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

29.83%

Pledged Shares

Institutional Holding

ROCE (avg)

4.33%

ROE (avg)

4.12%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

150

Industry P/E

Price to Book Value

6.38

EV to EBIT

130.91

EV to EBITDA

63.66

EV to Capital Employed

5.38

EV to Sales

12.18

PEG Ratio

22.73

Dividend Yield

0.10%

ROCE (Latest)

4.11%

ROE (Latest)

4.26%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 74.5 MM

NET SALES(HY)

At CNY 328.88 MM has Grown at 28.5%

ROCE(HY)

Highest at 4.36%

RAW MATERIAL COST(Y)

Fallen by -7.74% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 3.27 times

-10What is not working for the Company

PRE-TAX PROFIT(Q)

At CNY 3.52 MM has Fallen at -69.53%

NET PROFIT(Q)

At CNY 3.52 MM has Fallen at -68.45%

INTEREST COVERAGE RATIO(Q)

Lowest at 220.11

OPERATING PROFIT(Q)

Lowest at CNY 3.08 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 1.89 %

Here's what is working for Nanjing Hicin Pharmaceutical Co., Ltd.

Net Sales

At CNY 328.88 MM has Grown at 28.5%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Cash Flow

Highest at CNY 74.5 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debtors Turnover Ratio

Highest at 3.27 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -7.74% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Hicin Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 3.52 MM has Fallen at -69.53%

over average net sales of the previous four periods of CNY 11.55 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 3.52 MM has Fallen at -68.45%

over average net sales of the previous four periods of CNY 11.16 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest Coverage Ratio

Lowest at 220.11

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit

Lowest at CNY 3.08 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 1.89 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales